Código QR

Treatment of rheumatoid arthritis with biologic and targeted synthetic disease-modifying anti-rheumatic drugs in 2022 – real-world data from the Romanian Registry of Rheumatic Diseases

Objective. The study aimed at characterizing the evolution of RA treatment with b/tsDMARDs in Romania, since the end of the SARS-CoV-2 pandemic and the national approval of JAKi. Methods. Data on RA patients was obtained from the Romanian Registry of Rheumatic Diseases database between January 1st,...

Descrición completa

Gardado en:
Principais autores: Elena Rezus, Claudiu C. Popescu, Corina Mogosan, Claudiu Avram, Razvan-Constantin Ionitescu, Ioana Felea, Ileana-Cosmina Filipescu, Catalin Codreanu
Formato: Artigo
Idioma:Inglês
Publicado: Amaltea Medical Publishing House 2023-09-01
Series:Romanian Journal of Rheumatology
Assuntos:
rheumatoid arthritis
romanian registry of rheumatic diseases
biologic treatment
Acceso en liña:https://rjr.com.ro/articles/2023.3/RJR_2023_3_Art-07.pdf
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares